Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease
暂无分享,去创建一个
H. Sokol | P. Marteau | P. Seksik | L. Beaugerie | J. Cosnes | C. Landman | A. Bourrier | I. Nion‐Larmurier | A. Wisniewski | K. Perez | Kevin Pérez